Evaluation of the Clinical, Biochemical, Genotype and Prognosis Ofmut-Type Methylmalonic Acidemia in 365 Chinese Cases
Lili Liang,Shiying Ling,Yue Yu,Ruixue Shuai,Wenjuan Qiu,Huiwen Zhang,Linghua Shen,Shengnan Wu,Haiyan Wei,Yongxing Chen,Chiju Yang,Peng Xu,Xigui Chen,Hui Zou,Jizhen Feng,Tingting Niu,Haili Hu,Zhuwen Gong,Ting Chen,Xia Zhan,Xuefan Gu,Lianshu Han
DOI: https://doi.org/10.1136/jmg-2022-108682
2024-01-01
Journal of Medical Genetics
Abstract:BackgroundMethylmalonic acidemia (MMA), which results from defects in methylmalonyl-CoA mutase (muttype) or its cofactor, is the most common inherited organic acid metabolic disease in China. This study aimed to investigate the phenotype and genotype ofmut-type MMA in Chinese patients.MethodsWe recruited 365 patients withmut-type MMA; investigated their disease onset, newborn screening (NBS) status, biochemical metabolite levels, gene variations and prognosis; and explored the relationship between phenotype and genotype.ResultsThere were 152 patients diagnosed by tandem mass spectrometry (MS/MS) expanded NBS, 209 patients diagnosed because of disease onset without NBS and 4 cases diagnosed because of sibling diagnosis. The median age of onset was 15 days old, with a variety of symptoms without specificity. Urinary levels of methylmalonic acid and methylcitric acid (MCA) decreased after treatment. Regarding the prognosis, among the 152 patients with NBS, 50.6% were healthy, 30.3% had neurocognitive impairment and/or movement disorders and 13.8% died. Among the 209 patients without NBS, 15.3% were healthy, 45.9% had neurocognitive impairment and/or movement disorders and 33.0% died. In total, 179 variants were detected in theMMUTgene, including 52 novel variations. c.729_730insTT, c.1106G>A, c.323G>A, c.914T>C and c.1663G>A were the five most frequent variations. The c.1663G>A variation led to a milder phenotype and better prognosis.ConclusionThere is a wide spectrum of variations in theMMUTgene with several common variations. Although the overall prognosis ofmut-type MMA was poor, participation in MS/MS expanded NBS, vitamin B12responsive and late onset are favourable factors for the prognosis.